A drug with the SMILES Cc1c(CC(=O)N[C@H](C(=O)O)C(C)C)c(=O)oc2cc3c(cc12)CCC(C)(C)O3 has a human ether-à-go-go related gene (hERG) inhibition at 1uM of 10.515\%.
A {#drug|compound!} with the {SMILES__description} {SMILES#} has a {herg_central_at_1uM__names__noun} of {herg_central_at_1uM#}{herg_central_at_1uM__units}.
Cc1c(CC(=O)N[C@H](C(=O)O)C(C)C)c(=O)oc2cc3c(cc12)CCC(C)(C)O3
Cc1c(CC(=O)N[C@H](C(=O)O)C(C)C)c(=O)oc2cc3c(cc12)CCC(C)(C)O3
(2S)-3-methyl-2-[[2-(2,2,6-trimethyl-8-oxo-3,4-dihydropyrano[3,2-g]chromen-7-yl)acetyl]amino]butanoic acid